The significance of low PU.1 expression in patients with acute promyelocytic leukemia
Journal of Hematology & Oncology, 05/14/2012Zhu X et al.
The results showed that PU.1 expression was lower in patients with APL than other acute myeloid leukemia (AML) subtypes and there was also a trend towards increasing PU.1 expression from AML–M0 to AML–M5, with the exception of AML–M3 (APL). These observations suggested that PU.1 expression was reduced by PML–RARalpha in APL patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.